Overview
Cagrilintide is a long-acting amylin analogue designed to support weight management and metabolic control through once-weekly subcutaneous injections. The compound works by modulating appetite signals and gastric emptying to help reduce caloric intake.
What It Is
Cagrilintide represents a therapeutic approach to metabolic regulation. The substance “modulates gastric emptying and enhances satiety signals” while complementing insulin function for potential glucose control support.
Key Benefits
– Contributes to significant reductions in body weight
– Supports improved glycemic control in certain populations
– Promotes appetite regulation through amylin pathway activation
– Once-weekly injection schedule offers convenience
Dosing Protocol
Standard/Gradual Approach (3 mL reconstitution = ~3.33 mg/mL)
| Phase | Weekly Dose | Approximate Units |
|---|---|---|
| Weeks 1–2 | 0.25 mg | 7.5 units |
| Weeks 3–4 | 0.5 mg | 15 units |
| Weeks 5–8 | 1.0 mg | 30 units |
| Weeks 9–12 | 1.7 mg | 51 units |
| Weeks 13–16 (Optional) | 2.4 mg | 72 units |
Advanced/Aggressive Approach (2 mL reconstitution = 5 mg/mL)
| Phase | Weekly Dose | Approximate Units |
|---|---|---|
| Weeks 1–2 | 0.25 mg | 5 units |
| Weeks 3–4 | 0.5 mg | 10 units |
| Weeks 5–8 | 1.0 mg | 20 units |
| Weeks 9–12 | 1.7 mg | 34 units |
| Weeks 13–16 (Optional) | 2.4 mg | 48 units |
Reconstitution Instructions
Standard Approach (3 mL)
1. Draw 3.0 mL of bacteriostatic water into sterile syringe
2. Slowly inject water along vial wall to minimize foam
3. Gently swirl—avoid vigorous shaking
4. Store reconstituted solution at 2–8°C (refrigerator), protected from light
Advanced Approach (2 mL)
1. Draw 2.0 mL of bacteriostatic water into sterile syringe
2. Slowly inject water to minimize foam
3. Gently roll/swirl vial—no vigorous shaking
4. Refrigerate at 2–8°C, protected from light
Storage
– Lyophilized vials: Freeze at −20°C until mixing
– Reconstituted solution: Refrigerate at 2–8°C
– Use within 30 days of reconstitution
– Avoid repeated freeze-thaw cycles
Injection Protocol
– Frequency: Once weekly subcutaneous injection
– Cycle Length: 8–16 weeks (extendable for maintenance)
– Maximum Dose (Clinical Studies): Up to 4.5 mg weekly
– Timing: Any time of day; consistency is important
– Technique: Clean injection sites with alcohol swabs; rotate sites (abdomen, thigh, etc.); inject at 45–90° angle
Supplies Needed (8–16 week cycle)
– Peptide Vials: 1 vial (8 wks), 2 vials (12 wks), 3 vials (16 wks)
– Insulin Syringes: 8–16 syringes depending on cycle length
– Bacteriostatic Water: 1× 30ml bottle
– Alcohol Swabs: 1 box
Potential Side Effects
– Nausea and gastrointestinal discomfort
– Mild injection site reactions
– “Serious adverse events are rare but must be monitored”
– Slow dose escalation helps minimize GI side effects
Important Warnings
– Always use new, sterile insulin syringes
– Rotate injection sites
– Maintain consistent weekly schedule
– Monitor for gastrointestinal side effects; adjust titration if needed
– Consult qualified healthcare professionals before starting therapy
– This guide is for educational purposes only and does not diagnose, treat, cure, or prevent disease
Complementary Lifestyle Factors
– Focus on balanced, protein-rich nutrition
– Incorporate regular physical activity and recovery practices
– Manage stress and ensure consistent, quality sleep
Disclaimer: This information is provided for educational and research purposes only. Always consult a qualified healthcare provider before beginning any therapeutic protocol.